Charles Frsa

Charles Frsa is an accomplished Pharma management executive with extensive experience in international technical operational leadership across various sectors including pharmaceuticals, biopharmaceuticals, medical devices, FMCG, OTC, and nutrition.

With a background that spans from working with major players like Novartis and Roche to smaller biotechs such as BioPartners and InterMune, Charles brings a unique blend of expertise to the table.

His leadership abilities shine through as he has managed diverse teams of over 2000 employees in various locations globally with substantial budgets.

Noteworthy is his involvement in a startup that achieved biosimilar drug product approval in 2006, showcasing his adaptability in both large corporate settings and entrepreneurial ventures.

Charles is skilled in leading company integrations, turnarounds, and change management efforts, primarily focusing on operational areas like manufacturing, procurement, HSE, quality, business continuity, licensing, and business development.

A strong advocate of lean principles and innovation, he has successfully implemented cost-saving strategies throughout the business value chain while enhancing customer service experiences.

His educational background includes an MBA, Chartered Chemist, Chartered Scientist, and European Chemist qualifications, with a recent completion of the 'DQ 101 Decision Quality' course at Stanford University.

Recognized for his contributions, Charles was honored with a Churchill Fellowship in 1983 and became a Fellow of the Royal Society for the Encouragement of Arts, Manufactures and Commerce (FRSA) in 2011.

Proficient in International Executive Management & Operations, Charles is comfortable navigating various organizational levels, from the factory floor to the corporate headquarters and the boardroom.

Having a proactive approach to getting tasks accomplished efficiently, Charles embodies the characteristics of a 'Shaper,' as indicated by the Roche Enneagram Programme, where he was identified as a Type 8 Challenger.

He is a skilled communicator with experience in interacting with the media through TV, radio, and press engagements, adept at managing communication during both positive developments and crisis situations.

With dual Swiss and British citizenship, Charles Frsa brings a rich tapestry of professional experiences and a deep understanding of the industry.

His diverse roles in organizations such as Roche, InterMune, SkyePharma, BioPartners, Novartis, and Covidien have shaped him into a seasoned professional with a strong foundation in technical operations and strategic management.

Overall, Charles Frsa's journey is a testament to his resilience, adaptability, and exceptional leadership skills in the ever-evolving world of pharmaceuticals and related industries.